| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| KITE | Kite Pharma, Inc. | Steven B. Ruchefsky | Director | Jun 25, 2014 | Conversion | - | 1,892,840 | - | 1,892,840 | Jun 27, 2014, 06:42 PM | |
| KITE | Kite Pharma, Inc. | Jonathan M. Peacock | Director | Jun 25, 2014 | Other Acquisition or Disposition | $15.30 | 66,014 | 1,010,014 | 66,014 | Jun 27, 2014, 05:52 PM | |
| KITE | Kite Pharma, Inc. | Ran Nussbaum | Director | Jun 25, 2014 | Conversion | - | 2,201,936 | - | 1,076,390 | Jun 27, 2014, 05:50 PM | |
| KITE | Kite Pharma, Inc. | Farah Champsi | Director | Jun 25, 2014 | Other Acquisition or Disposition | $15.30 | 759,170 | 11,615,301 | 2,926,059 | Jun 27, 2014, 05:42 PM | |
| KITE | Kite Pharma, Inc. | Farah Champsi | Director | Jun 25, 2014 | Conversion | - | 2,166,889 | - | 2,166,889 | Jun 27, 2014, 05:42 PM | |
| KITE | Kite Pharma, Inc. | Roy Doumani | Director | Jun 25, 2014 | Conversion | - | 139,067 | - | 139,067 | Jun 27, 2014, 05:39 PM | |
| KITE | Kite Pharma, Inc. | Roy Doumani | Director | Jun 25, 2014 | Conversion | - | 31,865 | - | 31,865 | Jun 27, 2014, 05:39 PM | |
| KITE | Kite Pharma, Inc. | David Bonderman | Director | Jun 25, 2014 | Conversion | - | 2,358,084 | - | 2,358,084 | Jun 27, 2014, 05:31 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More